Baird Financial Group, Inc. Iovance Biotherapeutics, Inc. Transaction History

Baird Financial Group, Inc.

$50.2 Billion
Q3 2024

A detailed history of Baird Financial Group, Inc. transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Baird Financial Group, Inc. holds 193,845 shares of IOVA stock, worth $1.24 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

193,845

Previous 136,600 41.91%

Holding current value

$1.24 Million

Previous $1.1 Million 66.21%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$7.28 - $11.9 $416,743 - $681,215	57,245 Added 41.91%	193,845 $1.82 Million
Q2 2024 Aug 13, 2024	BUY	$7.78 - $14.19 $978,724 - $1.79 Million	125,800 Added 1164.81%	136,600 $1.1 Million
Q4 2023 Feb 14, 2024	BUY	$3.3 - $8.89 $35,640 - $96,012	10,800 New	10,800 $87,000
Q3 2022 Nov 14, 2022	SELL	$9.53 - $13.11 $1,705 - $2,346	-179 Reduced 0.93%	19,055 $183,000
Q2 2022 Aug 08, 2022	SELL	$6.38 - $18.33 $53,024 - $152,340	-8,311 Reduced 30.17%	19,234 $212,000
Q1 2022 May 13, 2022	BUY	$12.38 - $19.1 $12,318 - $19,004	995 Added 3.75%	27,545 $459,000
Q4 2021 Feb 09, 2022	SELL	$16.55 - $27.63 $74,756 - $124,804	-4,517 Reduced 14.54%	26,550 $507,000
Q3 2021 Nov 12, 2021	BUY	$20.35 - $26.63 $632,213 - $827,314	31,067 New	31,067 $766,000
Q2 2021 Aug 11, 2021	SELL	$16.33 - $33.07 $119,617 - $242,237	-7,325 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$28.67 - $52.59 $990,863 - $1.82 Million	-34,561 Reduced 82.51%	7,325 $232,000
Q4 2020 Feb 11, 2021	BUY	$28.04 - $50.26 $241,845 - $433,492	8,625 Added 25.93%	41,886 $1.94 Million
Q3 2020 Nov 12, 2020	BUY	$27.75 - $36.3 $117,465 - $153,657	4,233 Added 14.58%	33,261 $1.1 Million
Q2 2020 Oct 22, 2020	BUY	$27.21 - $41.0 $789,851 - $1.19 Million	29,028 New	29,028 $797,000
Q2 2020 Aug 14, 2020	SELL	$27.21 - $41.0 $300,534 - $452,845	-11,045 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$19.54 - $38.85 $215,819 - $429,098	11,045 New	11,045 $331,000

Others Institutions Holding IOVA

# of Institutions

312

Shares Held

237M

Call Options Held

3.77M

Put Options Held

1.7M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.01B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.

Account

Baird Financial Group, Inc. Iovance Biotherapeutics, Inc. Transaction History